NCT00250653View on ClinicalTrials.gov

A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Depressive Disorder
Interventions
DRUG

Saredutant succinate (SR48968C)

Trial Locations (1)

08807

Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY